Retraction Watch

Tsuji explains why JBC paper was retracted: Western blot problems

Last week, we reported on the retraction of a paper in the Journal of Biological Chemistry (JBC) that had one of the journal’s typically inscrutable retraction notices.:

This article has been withdrawn by the authors.

Late last week, we heard back from corresponding author Takashi Tsuji by email. It turns out one of our commenters had basically figured out what was wrong. It was, as seems to often be the case lately in retractions we cover, troubles with Western blots: Continue reading Tsuji explains why JBC paper was retracted: Western blot problems

An arXiv for all of science? F1000 launches new immediate publication journal

Late last year, we published an invited commentary in Nature calling for science to more formally embrace post-publication peer review, and stop fetishizing the published paper. One of the models we cited was Faculty of 1000 (F1000), “in which experts flag important papers in their field.”

So it’s not surprising that F1000 is announcing today that they’re launching a new journal, F1000 Research,

intended to address three major issues afflicting scientific publishing today: timely dissemination of research, peer review and sharing of data.

The journal will publish all submissions immediately, “beyond an initial sanity check:” Continue reading An arXiv for all of science? F1000 launches new immediate publication journal

University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

Stefano Fiorucci, a gastroenterology researcher at the University of Perugia in Italy, has been indicted for fraud and embezzlement, after a university investigation found that he had manipulated images in papers that he used to win about 2 million Euros in grant funding.

The case, which has so far resulted in four retractions and nine Expressions of Concern, has dragged on for several years. The trial is scheduled for July. It’s the first time that embezzlement charges have been brought against a scientist found to have committed fraud, according to reports in Umbria 24 and the Umbria Journal.

Fiorucci’s attorney, Stefano Bagianti, told Umbria 24 that there was Continue reading University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

Case Western explains why it withdrew press release about Andrulis origin of life paper

The wild and woolly saga of the paper that claims to solve “the puzzle of the origin and evolution of cellular life in the universe” continues.

Yesterday, Ivan wrote on his Tumblr about Case Western’s Erik D. Andrulis‘ paper, “Theory of the Origin, Evolution, and Nature of Life:” Continue reading Case Western explains why it withdrew press release about Andrulis origin of life paper

Errors force retraction of Blood paper on genetics of Hodgkin’s lymphoma

The authors of a paper published last September in Blood about alleged links between certain genes and Hodgkin’s lymphoma have retracted it, after realizing they’d made mistakes in their calculations.

The retraction notice for “Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups,” dated January 20 and signed by all of the authors, clearly explains what went wrong, taking pains to note that there was no misconduct involved: Continue reading Errors force retraction of Blood paper on genetics of Hodgkin’s lymphoma

PNAS retraction marks second for crystallography group

Two crystallographers who retracted a Structure paper last year have retracted a study about a similar subject in the Proceedings of the National Academy of Sciences, for similar reasons.

Here’s the notice for the paper, which has been cited 23 times, according to Thomson Scientific’s Web of Knowledge: Continue reading PNAS retraction marks second for crystallography group

Resveratrol researcher Dipak Das: My lab’s work was “99% correct”

Dipak Das, the UConn red wine researcher charged by his institution with rampant misconduct that will likely lead to dozens of retractions, is evidently a 99%-er — when it comes to accuracy, that is.

According to a statement purportedly from his lawyer refuting those charges, Das claims, among other things, that the output from his lab was nearly perfect. He also has a lot to say about a 60,000-page report that the statement says he may not have actually downloaded.

We might note a lot more things about the letter, which we received from Bill Sardi, president of Longevinex, a resveratrol company which has worked with Das. Sardi has been sending Das defenses since the story broke; we posted some of them and Derek Lowe has posted parts of another. But here’s the letter, in its entirety: Continue reading Resveratrol researcher Dipak Das: My lab’s work was “99% correct”

Should Iran have nuclear power? Paper addressing question retracted for authorship issues

When Renewable and Sustainable Energy Reviews accepted a paper last year arguing that nuclear power is Iran’s “assured right,” the editor, Lawrence Kazmirski, thought the article would be at least somewhat controversial. He was right — but for the wrong reason.

Shortly after publication, Kazmirski, director of the National Center for Photovoltaics at the National Renewable Energy Laboratory, in Golden, Colo., received an email from one of the listed co-authors of the article complaining that he and another co-author had not consented to submit the work. Kazmirski contacted the lead author, Afshin Mazandarani, who agreed to withdraw the paper.

The result was the following notice, which appeared in October (we only recently saw it): Continue reading Should Iran have nuclear power? Paper addressing question retracted for authorship issues

Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud

Following an investigation by the State University of New York (SUNY) Upstate into the work of one of its neuroscientists, the Journal of Neurochemistry has retracted a 2007 paper.